**Core Concept**
The question is testing the student's knowledge of the side effects of hypolipidemic drugs, specifically their impact on uric acid metabolism and gout symptoms. Uric acid is a byproduct of purine metabolism, and certain hypolipidemic drugs can affect its excretion or increase its production.

**Why the Correct Answer is Right**
The correct answer is a drug that inhibits the enzyme uric acid reabsorption in the kidneys, leading to increased uric acid excretion. However, in the case of this drug, it also increases the production of uric acid by inhibiting xanthine oxidase, an enzyme involved in purine catabolism. This dual effect can lead to a significant increase in serum uric acid levels, exacerbating gout symptoms.

**Why Each Wrong Option is Incorrect**
* **Option A:** This drug is a fibrate, which primarily works by activating peroxisome proliferator-activated receptor-alpha (PPAR-alpha), leading to increased lipolysis and reduced triglyceride levels. It does not have a significant impact on uric acid metabolism.
* **Option B:** This drug is a bile acid sequestrant, which works by binding to bile acids in the intestine and preventing their reabsorption. It does not affect uric acid levels or gout symptoms.
* **Option C:** This drug is a nicotinic acid, which primarily works by inhibiting lipolysis and reducing the release of free fatty acids from adipose tissue. It does not have a significant impact on uric acid metabolism.

**Clinical Pearl / High-Yield Fact**
When managing patients with gout, it's essential to consider the potential impact of hypolipidemic drugs on uric acid levels. Drugs that increase uric acid production or decrease its excretion can exacerbate gout symptoms, and alternative treatments should be considered.

**Correct Answer: A. This drug is Fenofibrate.**